ALA

0.00%

15.5¢ arovella therapeutics limited

On the Bright Side, page-27

First 27 Last

Share
Profile

Follow
Beale

3,684 Posts.

658

24/06/16

18:56

Post #: 18118357
Share

Originally posted by Augment ↑

Boris: good to see you're still hanging there. It has been frustrating for us all. But more frustrating to the
management who have been working hard to get deals over the line. In fact a number of deals could have been completed
but they were not as good as possible for SUDA shareholders. So negotiations continue.
Let me assure all shareholders that there will be many deals in many countries; some small and some large.
Atleast 3 major deals can happen at any stage in Europe, US and Asia. China is potentially very big as well.
Initially SUD-001 and SUD-002 will likely be the first deals to happen in countries such as Korea, India and China. They're the most advanced.
Longer term I still believe that Pfizer will buy into *word disallowed by google( SUD-003) following InVivo studies later in the year or early2017. Whether Pfizer want human studies on the new formula ( currently being patented) is to be determined, but assuming the studies of the innovative new formula give the results that is predicted then I believe a big deal with Pfizer is on the cards in 2017.
ArtiMist is well advanced and does not require the completion of the prereferal study to become a buyout deal.
A major pharma is looking seriously and as I've said for years I believe Novartis is the logical pharma because of their history in malaria. Applications for an EU grant of E6 mill is underway and this would be a nice boost to the bank balance and forestall Ny need for a CR, if other deals have not happened.
To all who "mock and knock" SUDA management on this forum you really have no idea of the difficulties a small Aussie Biotech
has in negotiating with 3 of the 5 major pharmas , nor mid sized pharma in other jurisdictions. The team is on the job and we will all see the results soon. The results will vary from small up fronts and larger ongoing payments, to I believe very big upfront payments and goal related payments.
I will be a buyer next week.

Expand

Hi Augment,

Great to have you back. We've missed you!! Thanks for the post. May I ask with regards to this paragraph below, is this something separate to Artimist trial funding, IE something the company can indeed bank into their own account as you suggest ? Could you elaborate on this.

Thanks buddy !!

"Applications for an EU grant of E6 mill is underway and this would be a nice boost to the bank balance and forestall any need for a CR, if other deals have not happened."

Last edited by Beale: 24/06/16

SUD Price at posting: 2.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 31 more messages in this thread...

First 27 Last

Add ALA (ASX) to my watchlist

(20min delay)
Last 15.5¢		Change 0.000(0.00%)		Mkt cap ! $163.0M

Open	High	Low	Value	Volume
15.5¢	15.8¢	15.0¢	$198.5K	1.280M

Buyers (Bids)

No.	Vol.	Price($)
15	438029	15.0¢

Sellers (Offers)

Price($)	Vol.	No.
15.5¢	283200	1

View Market Depth

No.	Vol.	Price($)
14	410529	0.150
9	272672	0.145
7	454047	0.140
4	383000	0.135
4	111077	0.130

Price($)	Vol.	No.
0.155	283200	1
0.160	222494	4
0.165	546319	9
0.170	930681	12
0.175	890346	10

Last trade - 16.10pm 04/10/2024 (20 minute delay)

ALA (ASX) Chart

On the Bright Side, page-27

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

On the Bright Side, page-27

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News